Skip Navigation

Strengthening the evidence for maternal and child health programs

EPSDT in Medicaid

Family Resource Brief

The Early and Periodic Screening, Diagnostic, and Treatment (EPSDT) benefit gives comprehensive and preventive health care services for kids under age 21 who are enrolled in Medicaid. Services are mandated by law to include:

The goal of EPSDT is to diagnose and treat health problems as early as possible. If a child enrolled in Medicaid needs a medically necessary service that will alleviate a medical condition or prevent a condition from getting worse, then the state must provide it. States also must help families by letting them know about EPSDT services and helping them use the services, such as helping to schedule appointments and helping with transportation to medical care.

Use this resource brief to help find care, services, and support for your child, learn more about EPSDT, and find tools to help you play a more active role in your child's EPSDT-related visits.

Find Care, Services, and Support

Do you have questions about Medicaid eligibility? applying for Medicaid? EPSDT services? finding care? These resources will help you find people in your state who can help answer your questions.

Learn More About EPSDT

Find Tools to Help You Play an Active Role in Your Child's EPSDT-Related Visits

Need More Information?

Early and Periodic Screening, Diagnostic, and Treatment (EPSDT) Services in Medicaid: Family Resource Brief, 2nd ed. (July 2014).

Author: Susan Brune Lorenzo, M.L.S., MCH Digital Library.
Reviewers: Lauren Agoratus, M.A., parent of a child with multiple disabilities, Family Voices and Family-to-Family Health Information Resource Center at the Statewide Parent Advocacy Network of N.J.; Beth Dworetzky, M.S., Catalyst Center; Olivia K. Pickett, M.A., M.L.S., MCH Digital Library.

This project is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under grant number U02MC31613, MCH Advanced Education Policy, $3.5 M. This information or content and conclusions are those of the author and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS or the U.S. Government.